Clinical viability of Fungitell, a new (1→3)-β-d-glucan measurement kit, for diagnosis of invasive fungal infection, and comparison with other kits available in Japan

Journal of Infection and Chemotherapy

Volumn 17, Issue 4, 2011, Pages 473-477

  Yoshida, Koichiro ^a   Shoji, Hisashi ^a   Takuma, Takahiro ^a   Niki, Yoshihito ^a  

^a SHOWA UNIVERSITY   (Japan)

Author keywords

(1 3) d glucan; Diagnostic marker; Invasive fungal infection

Indexed keywords

BETA GLUCAN;

ADOLESCENT; AGED; ARTICLE; BIOASSAY; CLINICAL EVALUATION; COMPARATIVE STUDY; CONTROLLED STUDY; DIAGNOSTIC EFFICIENCY; DIAGNOSTIC KIT; DIAGNOSTIC TEST ACCURACY STUDY; DIAGNOSTIC VALUE; DISEASE COURSE; FEMALE; HUMAN; JAPAN; MAJOR CLINICAL STUDY; MALE; PREDICTIVE VALUE; RECEIVER OPERATING CHARACTERISTIC; SENSITIVITY AND SPECIFICITY; SYSTEMIC MYCOSIS;

EID: 80052836278     PISSN: 1341321X     EISSN: 14377780     Source Type: Journal    
DOI: 10.1007/s10156-010-0198-6     Document Type: Article

References (17)

1. T Obayashi M Yoshida T Mori H Goto A Yasuoka H Iwasaki, et al. 1995 Plasma (1→3)-β-d-glucan measurement in diagnosis of invasive deep mycosis and fungal febrile episodes Lancet 345 17 20 7799700 10.1016/S0140-6736(95)91152-9 1:STN:280:DyaK2M%2FpslKrsw%3D%3D
2. K Yoshida 2006 Recent advances of serodiagnosis for systemic fungal infections Jpn J Med Mycol. 47 135 142 10.3314/jjmm.47.135 1:CAS:528: DC%2BD28XhtFCrtrrI (Pubitemid 44357798)
3. TJ Walsh EJ Anaissie DW Denning R Herbrecht DP Kontoyannis KA Marr, et al. 2008 Treatment of aspergillosis: clinical guidelines of infectious diseases society of America Clin Infect Dis 46 327 360 18177225 10.1086/525258 1:CAS:528:DC%2BD1cXitlKqt7c%3D (Pubitemid 351265310)
4. B De Pauw TJ Walsh JP Donnelly DA Stevens JE Edwards T Calandra, et al. 2008 Revised definitions of invasive fungal disease from the European organization for research and treatment of cancer/invasive fungal infections cooperative group and national institute of allergy and infectious diseases mycoses study group (EORTC/MSG) consensus group Clin Infect Dis 46 1813 1821 18462102 10.1086/588660
5. Deep-Seated Mycosis Guidelines Editorial Committee. Guidelines for management of deep-seated mycosis 2007 (in Japanese). Tokyo: Kyowakikaku; 2007.
6. Z Odabasi G Mattiuzzi E Estey H Kantarjian F Saeki RJ Rigde, et al. 2004 β-d-Glucan as a diagnostic adjunct for invasive fungal infections: validation, cutoff development, and performance in patients with acute myelogenous leukemia and myelodysplastic syndrome Clin Infect Dis 39 199 205 15307029 10.1086/421944 1:CAS:528:DC%2BD2cXovVejtbs%3D (Pubitemid 38971490)
7. C Pazos J Ponton AD Palacio 2005 Contribution of (1→3)-β-d- glucan chromogenic assay to diagnosis and therapeutic monitoring of invasive aspergillosis in neutropenic adult patients: a comparison with serial screening for circulating galactomannan J Clin Microbiol 43 299 305 15634986 10.1128/JCM.43.1.299-305.2005 1:CAS:528:DC%2BD2MXhtF2nu74%3D (Pubitemid 40096315)
8. L Ostrosky-Zeichner BD Alexander DH Kett J Vazquez PG Pappas F Saeki, et al. 2005 Multicenter clinical evaluation of the (1→3)-β-d-glucan assay as an aid to diagnosis of fungal infections in humans Clin Infect Dis 41 654 659 16080087 10.1086/432470 1:CAS:528:DC%2BD2MXhtVent7fL (Pubitemid 41170353)
9. JW Pickering HW Sant CAP Bowles WL Roberts GL Woods 2005 Evaluation of a (1→3)-β-d-glucan assay for diagnosis of invasive fungal infections J Clin Microbiol 43 5957 5962 16333082 10.1128/JCM.43.12.5957-5962.2005 1:CAS:528:DC%2BD28XjvF2qsA%3D%3D (Pubitemid 43100644)
10. M Ellis B al-Ramadi M Frinkelman U Hedstrom J Kristensen H Ali-Zadeh, et al. 2008 Assessment of the clinical utility of serial β-d-glucan concentrations in patients with persistent neutropenic fever J Med Microbiol 57 287 295 18287290 10.1099/jmm.0.47479-0 1:CAS:528:DC%2BD1cXktVWkt70%3D (Pubitemid 351358531)
11. F Persat S Ranque F Derouin A Michel-Nguyen S Picot A Sulahian 2008 Contribution of the (1→3)-β-d-glucan assay for diagnosis of invasive fungal infections J Clin Microbiol 46 1009 1013 18160456 10.1128/JCM.02091-07 (Pubitemid 351379994)
12. K Yoshida Y Niki H Mitekura M Nakajima H Kawane T Matsushima 2001 A discrepancy in the values of serum (1→3)-β-d-glucan measured by two kits using different methods Jpn J Med Mycol. 42 237 242 10.3314/jjmm.42.237 1:CAS:528:DC%2BD38XitFCrsw%3D%3D
13. K Yoshida Y Niki K Mohri Y Mori Y Obase M Fukuda, et al. 2005 Non-specific reactions in four methods measuring (1→3)-β-d-glucan levels in plasma J Jap Infect Dis. 79 329 340
14. K Yoshida N Miyashita Y Obase M Fukuda H Shoji S Yagi, et al. 2006 Clinical usefulness of the (1→3)-β-d-glucan measurement kit using the improved alkaline pretreatment method: comparison with conventional method J Jpn Infect Dis. 80 701 705
15. M Kawazu Y Kanda Y Nannya K Aoki M Kurokawa S Chiba, et al. 2004 Prospective comparison of the diagnostic potential of real-time PCR, double-sandwich enzyme-linked immunosorbent assay for galactomannan, and a (1→3)-β-d-glucan test in weekly screening for invasive aspergillosis in patients with hematological disorders J Clin Microbiol. 42 2733 2741 15184460 10.1128/JCM.42.6.2733-2741.2004 1:CAS:528:DC%2BD2cXlslals7o%3D (Pubitemid 38747529)
16. H Moro H Tsukada T Ohara R Susa Y Tanabe E Suzuki, et al. 2003 Comparison of four diagnosis methods using clinical blood by measuring (1→3)-β-d-Glucan J Jap Infect Dis 77 227 234
17. Y Horiguchi 2004 The performance of (1, 3)-β-d-glucan and Aspergillus galactomannan measurement for early diagnosis of invasive aspergillosis inpatients with hematological diseases J Jap Infect Dis. 78 566 573